Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a home exercise plan steady balance in parkinson disease?

NCT ID NCT07817862

Symptom relief Sponsor: Istanbul University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 14, 2026 · Last updated Sep 15, 2026 · Updated 1 time

Summary

Researchers at Istanbul University are testing whether a structured home exercise program paired with self-management education helps adults with Parkinson disease improve balance, walking, hand dexterity, and quality of life. The trial enrolls 55 people aged 45 to 80 who have had Parkinson disease for at least a year and are clinically stable. Participants are randomly assigned to the exercise and education program or to a control group that receives an educational booklet. The program includes posture, stretching, strengthening, gait, and balance exercises, with weekly phone calls to encourage adherence. Outcomes are measured at the start, after 8 weeks, and at Week 16, with balance as the main focus.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A home-based exercise program combined with self-management education
What this could lead to
If it works, this could give people with Parkinson disease a low-cost way to manage balance and walking problems from home, with weekly phone support to stay on track.
What could go wrong
The trial is small, with 55 participants, and home programs depend on people sticking with them. Results may not apply to those with more advanced disease or other health conditions that limit exercise.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 55 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

45 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Clinical diagnosis of Parkinson disease * Age 45 to 80 years * Parkinson disease diagnosed at least 1 year before enrollment * Clinically stable, with no change in medication dose or treatment plan during the previous 3 months * Modified Hoehn and Yahr stage 1 to 3 Exclusion Criteria: * Cardiovascular, pulmonary, or systemic disease that may limit exercise participation * Cognitive impairment or a communication barrier that prevents study participation * Participation in a regular rehabilitation program during the previous 3 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Parkinson disease (disorder) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Parkinson disease (disorder)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Istanbul University, Istanbul Faculty of Medicine

    Istanbul, Fatih, 34080, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.